- Yellow fever virus was isolated in 1927 and remains endemic today.
- Walter Reed proved mosquitoes transmitted the disease in 1901.
- Max Theiler's 17D vaccine earned the only Nobel Prize for a virus vaccine.
Yellow fever virus is a mosquito-borne RNA pathogen in the family Flaviviridae that causes severe liver damage, hemorrhaging, and death in roughly 20-50% of patients who develop severe illness.
Why It Matters
Key figure
1927
Year yellow fever virus was first isolated
Yellow fever drove some of the earliest large-scale public health interventions in the Western Hemisphere. The 1793 Philadelphia epidemic killed roughly 5,000 people, about 10% of the city's population, in a single summer. That disaster prompted the United States government to establish federal quarantine authority for the first time.
U.S. Army physician Walter Reed and his Yellow Fever Board proved in 1900-1901 that mosquitoes, not "foul air" or contaminated clothing, transmitted the disease. Reed's team conducted controlled experiments in Cuba, deliberately exposing volunteers to mosquito bites and soiled materials separately. Those bitten by infected mosquitoes developed yellow fever. Those exposed only to bedding and clothing did not.
The virus also holds a singular position in vaccine history. South African-born virologist Max Theiler received the 1951 Nobel Prize in Physiology or Medicine for developing the 17D vaccine strain. It remains the only Nobel Prize ever awarded specifically for a virus vaccine.
How It Works
Yellow fever virus belongs to the genus Flavivirus, named from the Latin flavus (yellow). Its genome is a single strand of positive-sense RNA, 10,862 bases long, encoding three structural proteins and seven nonstructural proteins. Mature virions are roughly 40-50 nanometers in diameter, wrapped in a lipid envelope studded with E glycoprotein dimers.
Key figure
17D
Vaccine strain still in use since 1937
Female Aedes aegypti mosquitoes are the primary vector. When an infected mosquito bites a human, the virus enters the bloodstream and targets hepatocytes. Viral replication damages the liver, producing jaundice, the yellowing of skin and eyes that gives the disease its name. Severe cases progress to hemorrhagic fever with a case fatality rate between 20% and 50%.
Transmission follows two cycles. In the urban cycle, Aedes aegypti mosquitoes spread the virus between humans in cities. In the sylvatic (jungle) cycle, the virus circulates among non-human primates and forest-dwelling mosquito species. Humans become infected when they enter forested areas where the sylvatic cycle is active.
Key Context
The isolation of yellow fever virus came in 1927 at the Rockefeller Foundation laboratory in Nigeria. Adrian Stokes, Johannes Bauer, and N. Paul Hudson isolated the Asibi strain from a 28-year-old West African patient named Asibi. Stokes himself died of yellow fever contracted during the research, one of several scientists killed by the virus they studied.
Theiler later attenuated the Asibi strain through 176 serial passages in chicken embryo tissue with the brain and spinal cord removed. The result was the 17D vaccine strain, first tested in Brazil in 1938. More than 80 years later, 17D remains the basis for every yellow fever vaccine in use worldwide. Over 600 million doses have been administered since its development.
Yellow fever remains a public health emergency. The WHO estimates 200,000 cases and 30,000 deaths annually, concentrated in sub-Saharan Africa and tropical South America. In 2025, confirmed cases in the Americas tripled compared to 2024, with 221 confirmed cases and 89 deaths across five countries by May. During the first seven weeks of 2026, 34 more cases and 15 deaths were confirmed in Bolivia, Colombia, Peru, and Venezuela. The virus has spread beyond traditional Amazonian endemic zones into Sao Paulo state and Colombia's Tolima department.
Almost all reported cases occurred in unvaccinated individuals.
FAQ
Is there a cure for yellow fever?
No antiviral treatment exists for yellow fever. Medical care is supportive, focused on managing dehydration, fever, and organ failure. Prevention through vaccination remains the only effective strategy.
How long does the yellow fever vaccine last?
A single dose of the 17D vaccine provides lifelong immunity in most recipients. The WHO Strategic Advisory Group of Experts concluded in 2013 that a booster dose is not needed, and the World Health Assembly formally removed the 10-year booster requirement in 2014.
Why is yellow fever called "yellow"?
The name refers to jaundice, the yellowing of skin and eyes caused by liver damage. The virus targets hepatocytes, and the resulting liver dysfunction allows bilirubin to accumulate in the blood.
Could yellow fever spread to Asia?
Competent Aedes aegypti mosquito populations exist throughout tropical Asia, and no natural immunity exists in the population. Researchers have debated since the 1930s why the virus has not established itself there. Factors may include cross-immunity from dengue, differences in mosquito competence, and limited historical trade routes, but no single explanation is definitive.
Related Reading
Sources
- Primary Research: The Yellow Fever Vaccine: A History (Frierson, Yale Journal of Biology and Medicine, 2010)
- Additional Context:
- Yellow fever and Max Theiler: the only Nobel Prize for a virus vaccine (Norrby, Journal of Experimental Medicine, 2007)
- Yellow Fever: A Reemerging Threat (Gardner and Ryman, Open Forum Infectious Diseases, 2015)
- Yellow Fever Fact Sheet (World Health Organization)
- Sustained yellow fever transmission in South America (PAHO, 2026)
- Major Walter Reed and the Eradication of Yellow Fever (Army History)
Fact Check: Claim-by-Claim Verification Verified
All major claims verified against primary sources. Key dates, attributions, and statistics confirmed through WHO, PAHO, PMC, and Nobel Prize records.
Sources used for verification
- The Yellow Fever Vaccine: A History - pmc.ncbi.nlm.nih.gov
- Yellow fever and Max Theiler: the only Nobel Prize for a virus vaccine - pmc.ncbi.nlm.nih.gov
- Yellow Fever Fact Sheet - who.int
- PAHO 2026 Yellow Fever Report - paho.org
- Yellow Fever: A Reemerging Threat - pmc.ncbi.nlm.nih.gov
